Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion

Annals of Clinical Biochemistry

Volumn 44, Issue 3, 2007, Pages 264-272

  Elsammak M , Mohamed Y ^a   Morsi, Tamer S ^b   Khamis, Hend I ^a   Ragab, Mahmoud S ^a   Zaki, Moyassar A ^a   Abdel Hadi, Mona ^b   Hassan, Hoda A ^b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; OSTEOPONTIN; CARCINOEMBRYONIC ANTIGEN; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG EXTRAVASCULAR FLUID; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; AGED; BLOOD; EGYPT; METABOLISM; MIDDLE AGED; TUBERCULOSIS;

ADULT; AGED; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; EGYPT; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; OSTEOPONTIN; PLEURAL EFFUSION; TUBERCULOSIS;

EID: 34250333854     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307780480918     Document Type: Article

References (37)

1. Ackerman Z, Reynolds TB. Evaluation of pleural fluid in patients with cirrhosis. J Clin Gastroenterol 1997; 25: 619-22
2. Burgess LJ, Maritz FJ, Taljaard JJ. Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 1995; 107: 1604-9
3. Yilmaz Turay U, Yildirim Z, Turkoz Y, et al. Use of pleural fluid C-reactive protein in diagnosis of pleural effusions. Respir Med 2000; 94: 432-5
4. Garcia-Pachon E, Soler MJ, Padilla-Navas I, Romero V, Shum C. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis. Respiration 2005; 72: 486-9
5. Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology 2004; 9: 66-9
6. Diao H, Kon S, Iwabuchi K. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 2004; 21: 539-50
7. Comabella M, Pericot I, Goertsches R, et al. Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 2005; 158: 231-9
8. Abel B, Kurrer M, Shamshiev A, Marty RR, Eriksson U, Gunthert U, Kopf M. The osteopontin -CD44 pathway is superfluous for the development of autoimmune myocarditis. Eur J Immunol 2006; 36: 494-9
9. Ang C, Chambers AF, Tuck AB, Winquist E, Izawa JI. Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder. BJU Int 2005; 96: 803-5
10. Arai M, Yokosuka O, Kanda T, et al. Serum osteopontin levels in patients with acute liver dysfunction. Scand J Gastroenterol 2006; 41: 102-10
11. Angelucci A, Festuccia C, Gravina GL, et al. Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate 2004; 59: 157-66
12. Donati V, Boldrini L, Dell'Omodarme M, et al. Osteopontin expression and prognostic significance in non-small cell lung cancer. Clin Cancer Res 2005; 11: 6459
13. Ariztia EV, Subbarao V, Solt DB, Rademaker AW, Iyer AP, Oltvai ZN. Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation. Exp Cell Res 2003; 288: 257-67
14. Pass HI, Lott D, Lonardo F, et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 2005; 353: 1564-73
15. Chen ML, Yu WC, Lam CW, Au KM, Kong FY, Chan AY. Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy. Clin Chim Acta 2004; 341: 101-7
16. Fijalkowski M, Graczyk J. Tuberculous pleurisy - still difficult diagnostic problem. Pol Merkuriusz Lek 2001; 11: 389-93
17. Ferrer J. Pleural tuberculosis. Eur Respir J 1997; 10: 942-7
18. Abel B, Freigang S, Bachmann MF, Boschert U, Kopf M. Osteopontin is not required for the development of Th1 responses and viral immunity. J Immunol 2005; 175: 6006-13
19. Banerjee A, Apte UM, Smith R, Ramaiah SK. Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease. J Pathol 2006; 208: 473-85
20. Chellaiah MA, Hruska KA. Osteopontin. Drug News Perspect 1998; 11: 350-5
21. Vestal AL. Procedures for the Isolation and Identification of Mycobacteria. DHEW Publication No (CDC) 75-8230. Washington DC: Department of Health, Education and Welfare, 1975
22. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 2004; 10: 190-212
23. Hellyer TJ, DesJardin LE, Hehman GL, Cave MD, Eisenach KD. Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis. J Clin Microbiol 1999; 37: 290-5
24. Burtis CA, Ashwood ER. Tietz Fundamental of Clinical Chemistry. 4th edn. Philadelphia: WB Saunders, 1996
25. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-5
26. Romero S, Candela A, Martin C, Hernandez L, Trigo C, Gil J. Evaluation of different criteria for the separation of pleural transudates from exudates. Chest 1993; 104: 399-404
27. Costa M, Quiroga T, Cruz E. Measurement of pleural fluid cholesterol and lactate dehydrogenase. A simple and accurate set of indicators for separating exudates from transudates. Chest 1995; 108: 1260-3
28. Garcia-Pachon E, Soler MJ, Padilla-Navas I, Romero V, Shum C. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis. Respiration 2005; 72: 486-9
29. Valdes L, San Jose E, Alvarez D, Valle JM. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Resp J 1996; 9: 747-51
30. Andreasyan NA, Hairapetian HL, Sargisova YG, Mardanyan SS, Badalyan LT, Khanoyan AS. Activity of adenosine deaminase and its isoforms in pleural fluid in tuberculous pleuritis. Med Sci Monit 2002; 8: 708-12
31. Burgess LJ, Reuter H, Taljaard JJ, Doubell AF. Role of biochemical tests in the diagnosis of large pericardial effusions. Chest 2002; 121: 495-9
32. Tozkoparan E, Deniz O, Cakir E, et al. The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy. Int J Tuberc Lung Dis 2005; 9: 1040-5
33. Minoretti P, Falcone C, Calcagnino M, et al. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J 2006; 27: 802-7
34. O'Regan A. The role of osteopontin in lung disease. Cytokine Growth Factor Rev 2003; 14: 479-88
35. O'Regan A, Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 2000; 81: 373-90
36. Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology 2004; 9: 66-9
37. Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology 2004; 9: 66-9